Incepta Pharmaceuticals Ltd. and DataFort Limited Celebrate Successful Robo2 BPA Go-Live and Awareness Program
Incepta Pharmaceuticals Ltd., one of Bangladesh’s leading pharmaceutical manufacturers, has partnered with DataFort Limited to launch Robo2 BPA, a cutting-edge Business Process Automation platform designed to modernize pharmaceutical operations. The go-live and awareness program, held earlier this month, marked a major milestone in Incepta’s digital transformation journey—drawing attention from thousands of industry professionals and technology leaders.
Hosted at Incepta’s headquarters, the event brought together top executives including Mr. Mahbubul Anam (Managing Director, Expo Group), Mr. Khusru Mahmudul Hasan (CEO & Director, Expo Group), and Mr. Abdul Muktadir (Chairman & Managing Director, Incepta Pharmaceuticals), alongside department heads and influential figures from across the pharmaceutical sector.
Throughout the program, attendees experienced firsthand how Robo2 BPA’s no-code automation features empower business users—without technical backgrounds—to design, deploy, and manage complex workflows with ease. From regulatory compliance to production planning and internal approvals, Incepta teams have already automated several mission-critical processes, reducing turnaround times and boosting operational agility.
Speaking at the event, the CEO of Incepta Pharmaceuticals remarked, “This successful go-live and awareness program is a testament to our shared commitment to introducing cutting-edge technologies and solutions to the pharmaceutical industry. Our partnership with DataFort Limited has allowed us to take the lead in moving the industry forward, and we are proud.”
By adopting Robo2 BPA, Incepta Pharmaceuticals is not only enhancing productivity and compliance but also setting a benchmark for scalable, user-driven automation in life sciences.